A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder
Clinical trial NCT05729373 · COMPLETED
Trial details
- NCT number
- NCT05729373
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2025-09-26
- Enrollment
- 434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.